News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
Format:Category:
1 Results– filtered by:#Vigeneron
Ecosystem
Gene therapy startup Vigeneron begins phase I of clinical trial
The hereditary disease retinitis pigmentosa is one of the most common causes of vision loss in middle adulthood. Previously incurable, gene therapies now promise success in treating the disease. The Munich startup Vigeneron is developing such a therapy and is now beginning phase I of clinical trial.
25.08.23
3 Min.